News for 'Pfizer Inc'

India undermining intellectual property: Pfizer

India undermining intellectual property: Pfizer

Rediff.com14 Mar 2013

Pfizer alleged India has taken steps that call into question the sustainability of foreign investments and the ability to compete fairly.

Pfizer may merge Duchem with itself

Pfizer may merge Duchem with itself

Rediff.com24 Apr 2006

Pfizer sells Benadryl, Listerine to J&J

Pfizer sells Benadryl, Listerine to J&J

Rediff.com1 Jan 2008

Pfizer Ltd, the Indian arm of the world's largest pharmaceutical company Pfizer Inc, is selling four consumer health brands that are household names in India Listerine, Benadryl, Caladryl and Benylin to Johnson & Johnson Ltd for Rs 214.85 crore, as part of J&J's acquisition of Pfizer's global consumer health business in June 2006.

Pfizer shows mettle, to launch 240 drugs

Pfizer shows mettle, to launch 240 drugs

Rediff.com18 Dec 2007

While Pfizer, the world's largest pharmaceutical company, is being criticised for its inability to come up with blockbuster drugs, its global research and development head said the company was working on one of its largest ever assemblage of drugs.

BMC claims Mumbai received bid from Pfizer for vaccine, company denies

BMC claims Mumbai received bid from Pfizer for vaccine, company denies

Rediff.com25 May 2021

After Brihanmumbai Municipal Corporation Commissioner Iqbal Singh Chahal claimed that Mumbai has received a bid from Pfizer in response to its COVID-19 vaccine procurement tender, Pfizer issued a statement clarifying that it has made no such bid.

Pfizer offers to raise stake in Indian unit

Pfizer offers to raise stake in Indian unit

Rediff.com14 Apr 2009

The world's biggest drug maker Pfizer Inc has offered about Rs 680 crore to raise its stake in its Indian subsidiary to 75 per cent from 41 per cent. The offer of Rs 675 per share, however, is unlikely to find takers, since Pfizer share price rose 10.02 per cent to close at Rs 685.4 per share on the Bombay Stock Exchange (BSE) on Monday, analysts feel.

Pfizer may counter Daiichi's Ranbaxy offer

Pfizer may counter Daiichi's Ranbaxy offer

Rediff.com13 Jun 2008

US giant expected to bid for 65% non-promoter stake.

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Rediff.com10 Nov 2020

After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.

Nicholas Piramal to buy Pfizer's UK facility

Nicholas Piramal to buy Pfizer's UK facility

Rediff.com15 Jun 2006

Nicholas Piramal India Ltd said on Thursday its UK subsidiary has entered into an agreement to acquire the manufacturing facility of global pharma company Pfizer Inc at Morpeth, UK, on an asset purchase basis.

Pfizer to pay $55 million to settle Protonix case

Pfizer to pay $55 million to settle Protonix case

Rediff.com13 Dec 2012

US Department of Justice had charged Wyeth for promoting its acid reflux drug Protonix for unapproved uses and making unproven claims.

Pfizer in dock for drug trials on kids

Pfizer in dock for drug trials on kids

Rediff.com14 Oct 2003

The world's largest pharmaceutical company is accused of carrying out drug trials of Trovan -- an antibiotic -- on Nigerian children injuring and killing them.

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Rediff.com17 Nov 2020

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Rediff.com13 Sep 2014

Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Rediff.com25 May 2021

Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.

'India examining possibilities': Govt on Pfizer Covid vaccine

'India examining possibilities': Govt on Pfizer Covid vaccine

Rediff.com17 Nov 2020

The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.

Pfizer, BioNTech to supply vaccines at Tokyo Olympics

Pfizer, BioNTech to supply vaccines at Tokyo Olympics

Rediff.com7 May 2021

According to the organisers, based on the feedback from the NOCs and NPCs, it is expected that a significant proportion of Games participants will have been vaccinated before arriving in Japan. The new MoU adds to these efforts.

Govt needs to define COVID vaccine strategy: Rahul

Govt needs to define COVID vaccine strategy: Rahul

Rediff.com11 Nov 2020

Pfizer Inc and BioNTech SE have said that their vaccine candidate has been found to be more than 90 per cent effective in preventing COVID-19.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Dom's Take: The race for COVID-19 vaccine

Dom's Take: The race for COVID-19 vaccine

Rediff.com17 Nov 2020

Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, Wyeth sue Ranbaxy over drug

Rediff.com3 May 2010

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune.

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

Tokyo organisers say fears of virus banished by success of test event

Tokyo organisers say fears of virus banished by success of test event

Rediff.com10 Nov 2020

All athletes and staff took daily PCR tests during their time in Japan and their movements were heavily restricted.

 Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Rediff.com13 Jun 2013

Shares in Sun Pharmaceutical Industries fell by more than 5 per cent after the company settled a patent suit with Pfizer Inc related to its acid-reflux drug for $550 million.

The world's largest wine company is.?

The world's largest wine company is.?

Rediff.com13 Jul 2004

Take the Rediff Business Quiz and see if you know which are the world's top steel, pharma, wine comapnies.

Atorvastatin: Dr Reddy's to contest Pfizer's suit

Atorvastatin: Dr Reddy's to contest Pfizer's suit

Rediff.com5 Jan 2011

On December 27 last year, Pfizer had moved to the US District Court for the District of Delaware against Dr Reddy's Laboratories Ltd and Dr Reddy's Laboratories Inc for infringement of Pfizer's crystalline atorvastatin patent.

Global drug cos bag 392 India patents in 32 months

Global drug cos bag 392 India patents in 32 months

Rediff.com22 Oct 2008

Global pharma majors such as Novartis, Roche and Pfizer have secured 392 medicine patents in less than three years of India changing its patent laws to allow product patenting system for drugs in the country. While Swiss multinational Hoffmann La Roche leads the tally with 34 patent grants, Novartis AG and Pfizer Inc follow closely with 25 and 24 respectively.

Pharmacist held for sale of bootleg Viagra

Pharmacist held for sale of bootleg Viagra

Rediff.com28 Sep 2005

Police believe the bulk powder and replica tablets, which looked exactly like the genuine article, came from India.

Now, easy to buy Viagra in China

Now, easy to buy Viagra in China

Rediff.com30 Sep 2004

The popular anti-impotence drug will be available in about 2,000 drugstores in major cities.

India's IPR regime: Another setback for a multinational drugmaker

India's IPR regime: Another setback for a multinational drugmaker

Rediff.com7 Sep 2015

India rejects patent on Pfizer's arthritis drug

World Cup meets could see spike in COVID in Brazil

World Cup meets could see spike in COVID in Brazil

Rediff.com24 Nov 2022

On World Cup game days, many Brazilians get time off work to pack into bars and restaurants or gather for home barbecues to watch the games, rooting for a national team seeking its sixth world champion title in Qatar.

Anti-Olympics campaign gains traction online in Japan

Anti-Olympics campaign gains traction online in Japan

Rediff.com7 May 2021

In two days since its launch, an online campaign (https://www.change.org/p/cancel-the-tokyo-olympics-to-protect-our-lives-stoptokyoolympic) called "Stop Tokyo Olympics" has gathered over 210,000 signatures, exceeding its initial 200,000 goal.

IOC reassures anxious Japan Olympics will be safe

IOC reassures anxious Japan Olympics will be safe

Rediff.com19 May 2021

IOC chief said he believed more than 80 per cent of residents of the Olympic Village would be vaccinated or booked for vaccination ahead of the Games

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.

Japan denies considering vaccine priority for Olympic athletes

Japan denies considering vaccine priority for Olympic athletes

Rediff.com13 Apr 2021

New infections have spiked ahead of the Olympics, which are set to start in July

India partly revokes Roche cancer drug patent

India partly revokes Roche cancer drug patent

Rediff.com5 Aug 2013

Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.

Delhi HC extends relief to pharma firms in drug ban case

Delhi HC extends relief to pharma firms in drug ban case

Rediff.com21 Mar 2016

Several companies, including Indian units of Abbott Laboratories and Pfizer Inc, and domestic firms like Cipla Ltd and Macleods Pharmaceuticals, went to the Delhi High Court to try to get the ban lifted.

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

Rediff.com1 Sep 2020

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.